MA44019A - Modulateurs de cftr modifiés par deutérium - Google Patents

Modulateurs de cftr modifiés par deutérium

Info

Publication number
MA44019A
MA44019A MA044019A MA44019A MA44019A MA 44019 A MA44019 A MA 44019A MA 044019 A MA044019 A MA 044019A MA 44019 A MA44019 A MA 44019A MA 44019 A MA44019 A MA 44019A
Authority
MA
Morocco
Prior art keywords
deuterium modified
cftr modulators
modified cftr
modulators
deuterium
Prior art date
Application number
MA044019A
Other languages
English (en)
Inventor
I Robert Silverman
Original Assignee
Vertex Pharmaceuticals Europe Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharmaceuticals Europe Ltd filed Critical Vertex Pharmaceuticals Europe Ltd
Publication of MA44019A publication Critical patent/MA44019A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA044019A 2016-02-12 2017-02-10 Modulateurs de cftr modifiés par deutérium MA44019A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662294543P 2016-02-12 2016-02-12

Publications (1)

Publication Number Publication Date
MA44019A true MA44019A (fr) 2018-12-19

Family

ID=59563573

Family Applications (1)

Application Number Title Priority Date Filing Date
MA044019A MA44019A (fr) 2016-02-12 2017-02-10 Modulateurs de cftr modifiés par deutérium

Country Status (6)

Country Link
US (1) US20190048020A1 (fr)
EP (1) EP3414235A4 (fr)
AU (1) AU2017217806A1 (fr)
CA (1) CA3014275A1 (fr)
MA (1) MA44019A (fr)
WO (1) WO2017139569A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1249893A1 (zh) 2015-03-31 2018-11-16 Vertex Pharmaceuticals (Europe) Limited 氘代vx-661

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9453027B2 (en) * 2009-07-27 2016-09-27 Daljit Singh Dhanoa Deuterium-enriched pyridinonecarboxamides and derivatives
HRP20250965T1 (hr) * 2012-06-15 2025-10-10 Sun Pharmaceutical Industries, Inc. Deuterirani derivati ruksolitiniba
HUE040366T2 (hu) * 2013-08-08 2019-03-28 Galapagos Nv CFTR modulátor tieno[2,3-c]piránok

Also Published As

Publication number Publication date
EP3414235A4 (fr) 2019-01-02
CA3014275A1 (fr) 2017-08-17
WO2017139569A1 (fr) 2017-08-17
EP3414235A1 (fr) 2018-12-19
US20190048020A1 (en) 2019-02-14
AU2017217806A1 (en) 2018-08-16

Similar Documents

Publication Publication Date Title
MA55328A (fr) Modulateurs de ror-gamma
EP3619310A4 (fr) Polynucléotides modulateurs
MA50014A (fr) Modulateurs de k-ras
EP3631917A4 (fr) Modulateur optique à base de fibres
MA53943A (fr) Modulateurs de ror-gamma
LT3525830T (lt) Pirolbenzodiazepino konjugatai
MA42061A (fr) Modulateurs de k-ras
PT3239151T (pt) Moduladores de p2x7
DK3490986T3 (da) Piperidin-cxcr7-receptormodulatorer
EP3432059A4 (fr) Modulateur optique
EP3333619A4 (fr) Modulateur optique
MA42954A (fr) Potentialisateurs cftr deutérés
EP3432058A4 (fr) Modulateur optique
IL261341B (en) Branch instruction
DK3242685T3 (da) Cxcr4-bindende molekyler
EP3477362A4 (fr) Modulateur électro-optique
DK3544634T3 (da) MET-antistof-lægemiddelkonjugater
EP3694528A4 (fr) Modulateurs de mtorc1
EP3532062A4 (fr) Modulateurs de ror-gamma
EP3504145C0 (fr) Agencement de rotateur
EP3459941A4 (fr) Dérivé de pyrrolidine
DK3606953T3 (da) Fgfr3-bindende molekyler
CR20180079A (es) Moléculas de fusión
EP3541403A4 (fr) Conjugués ligand-ionophore
EP3463423A4 (fr) Conjugués glucagon-t3